ZWZhenpeng Wang

Zhenpeng Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhenpeng Wang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    循环炎症蛋白成纤维细胞生长因子21与骨质疏松以及骨折的关系研究

    by 柯伽 周, 振棚 王, 玫 张

    目的 系统性筛选循环炎症蛋白(circulating inflammatory proteins, CIPs)中影响骨质疏松症(osteoporosis, OP)和骨折的潜在靶点,通过临床样本验证其与骨密度(bone mineral density, BMD)的关联,为骨代谢调控提供新靶点证据。 方法 利用双向孟德尔随机化分析CIPs与OP和骨折的因果关系。纳入2型糖尿病(type 2 diabetes mellitus, T2DM)和健康人群,收集患者一般资料,检测并比较合并OP的T2DM组(DOP)、无OP的T2DM组(NDOP)及对照组的成纤维细胞生长因子21(fibroblast growth factor 21, FGF21)与骨代谢指标。 结果 EBI GWAS Catalog数据库中获取的共91种CIPs中,逆方差加权(inverse variance weighting, IVW)分析显示FGF21同时与OP和过去5年发生骨折存在潜在因果关系,其水平升高增加OP风险〔比值比(odds ratio, OR)=1.003,95%置信区间(confidence interval, CI):1.001~1.005;P=0.004〕和过去5年发生骨折风险(OR=1.004,95%CI:1.000~1.008;P=0.038),反向MR显示OP和过去5年发生骨折对正向分析中确定的FGF21在内的8种CIPs没有因果影响。临床研究显示:DOP组血浆FGF21〔396.92 (308.98,523.94) pg/mL〕高于NDOP组〔346.88(283.82,466.86) pg/mL〕和对照组〔233.66(169.95,327.78) pg/mL〕(均Pβ=-0.003,95%CI:-0.004~-0.002,P<0.0001)和全髋T值(β=-0.002,95%CI:-0.003~-0.001,P<0.0001)呈负相关,而在T2DM中,FGF21与腰椎(β=-0.003,95%CI:-0.004~-0.0014,P<0.0001)和全髋T值(β=-0.001,95%CI:-0.0022 ~-0.0005,P=0.002)呈负相关,调整上述协变量后,负相关同样存在。 结论 FGF21增加OP和过去5年发生骨折的风险,且存在因果关系,是T2DM骨骼健康受损的潜在危险因素。

  • Assessment of fracture risk in diabetic patients

    by Zhenpeng Wang, Mei Zhang, Dan Jia

    Patients with diabetes often experience reduced bone strength, resulting in a higher fracture risk. This decline and increased susceptibility stem from intricate interactions within the bone microstructure. However, current gold standard methods for assessing bone strength, such as bone mineral density, and widely-used fracture risk assessment tools do not accurately predict fracture risk in diabetic patients. Therefore, it is crucial to incorporate additional indicators that evaluate bone quality and specific markers relevant to diabetes to enhance the accuracy of predictive models. Moreover, the selection of appropriate algorithms for model construction is essential. This review aims to introduce indicators from both imaging examinations and laboratory indicators that hold significant value for inclusion in fracture risk prediction models for diabetic patients. Additionally, this study provides an overview of the research progress in fracture risk prediction models for diabetic patients, serving as a valuable reference for clinical practice.